Maze Therapeutics (MAZE) Fair Value & DCF

MAZE$33.90-0.43 -1.25%
BiotechnologyGrowth Stock
Compare
Market cap$1.85BEnterprise value$1.96BRevenue (TTM)$20.00MMarket position—

Score

64
Neutral
Value
56
Quality
37
Growth
100

Maze Therapeutics, Inc. (MAZE) trades at $33.90 on $1.85B of equity value, with a trailing P/E of -12.90. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Maze Therapeutics (MAZE) Fair Value & DCF

MAZE price $33.90 -0.43 -1.25%

Ticker
MAZE
Price
$33.90
Change
-0.43 -1.25%
Market cap
$1.85B
Dividend yield
0.00%
Beta
2.03
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
64
Value
56
Quality
37
Growth
100

Stocklytics score rationale: value 56, quality 37, growth 100.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener